This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
6. References
Banks, M. A., Porter, D. W., Pailes, W. H., Schwegler-Berry, D., Martin, W. G., and Castranova, V., 1991, Taurine content of isolated rat alveolar type I cells, Comp. Biochem. Physiol. B 100:795–799.
Barua, M., Liu, Y., and Quinn, M. R., 2001, Taurine chloramine inhibits inducible nitric oxide synthase and TNF-α gene expression in activated alveolar macrophages: decreased NF-B activation and I B kinase activity, J. Immunol. 167:2275–2281.
Beauchamp, C. and Fridovich, I., 1971, Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels, Anal. Biochem. 44:276–278.
Carmen, S., Gage, F. H., and Shults, C. W., 1991, Partial lesion of the substanis nigra: relation between extent of lesion and rotational behaviour, Brain Res. 553:275-283.
Chorazy, M., Kontny, E., Marcinkiewicz, J., and Maslinski, W. 2002, Taurine chloramine modulates cytokine production by human peripheral blood mononuclear cells, Amino Acids 23:407–413.
Crichton, R. R. and Ward, R. J., 2005, in Metal-Based Neurodegeneration: From Molecular Mechanisms to Therapeutic Strategies, J Wiley and Sons, Chichester, UK, in press.
Dahchour, A. and De Witte, P., 2003, Effects of acamprosate on excitatory amino acids during multiple ethanol withdrawal period, Alcohol Clin. Exp. Res. 27:465–470.
Datla, K. P., Blunt, S. B., and Dexter, D. T., 2001, Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions, Movement Disord. 16:424–434.
Della Corte, L., Crichton, R. R., Duburs, G., Nolan, K., Tipton, K. F., Tirizitis, G., and Ward, R. J., 2002, The use of taurine analogues to investigate taurine functions and their potential therapeutic application, Amino Acids 23:367–379.
Hissin, P. J. and Hilf, R., 1976, A fluorometric method for the determination of reduced glutathione in tissues, Anal. Biochem. 74:214–216.
Kim, H. W., Kim, J. H., An, H. S., Park, K. K., Kim, B. K., and Park, T., 2003, Myo-inositol restores the inflammation-induced down-regulation of taurine transport by the murine macrophage cell line, RAW 264.7, Life Sci. 73:2477–2489.
Liu, Y., Schuller-Levis, G., and Quinn, M. R., 1999, Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 production is inhibited by taurine chloramine in rat C6 glioma cells, Immunol. Lett. 70:9–14.
Mark, L. P., Prost, R. W., Ulmer, J. L., Smith, M. M., Daniels, D. L., Strottmann, J. M., Douglas Brown, W., and Hacein-Bey, L., 2001, Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging, Am. J. Neuroradiol. 22:1813–1824.
Olszowski, S., Olszowska, E., Kusior, D., and Szneler, E., 2002, Sulphoacetaldehyde as a product of taurine chloramine peroxidation, at site of inflammation Amino Acids 22:145–153.
Palmi, M., Youmbi, G. T., Fusi, F. Sgaragli. G. P., Dixon, H. B., Frosini, M., and Tipton, K. F., 1999, Potentiation of mitochondrial Ca2+ sequestration by taurine, Biochem. Pharmacol. 58:1123–1131.
Park, E., Jia, J., Quinn, M. R., and Schuller-Lewis, G., 2002, Taurine chloramine inhibits lymphocyte proliferation and decreases cytokine production in activated human leukocytes, Clin. Immunol. 102:179–184.
Paxinos, G. and Watson, C. 1986, The Rat Brain in Stereotaxic Co-ordinates, 2nd edn, Academic Press, London.
Perese, D. A., Ulman, J., Viola, J., Ewing, S. E., and Bankiewicz, K. S., 1989, A 6-hydroxydopamine-induced selective Parkinsonian rat model, Brain Res. 494:285–293.
Peters, T. J. and Batt, R. M., 1985, Effect of predinosolone on small intestinal mucosa of the rat, Clin. Sci. 50:511–523.
Schuller-Levis, G. B. and Park, E., 2003, Taurine new implications for an old amino acid, FEMS Microbiol. Lett. 226:195–202.
Son, M., Ko, J. I., Kim W. B., Kang, H. K., and Kim, B. K., 1998, Taurine can ameliorate inflammatory bowel disease in rats, Adv. Exp. Med. Biol. 442:291–298.
Tappaz, M. L., 2004, Taurine biosynthetic enzymes and taurine transporter: molecular identification and regulations, Neurochem. Res. 29:83–96.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, LLC
About this paper
Cite this paper
Ward, R. et al. (2006). Neuroprotection by Taurine and Taurine Analogues. In: Oja, S.S., Saransaari, P. (eds) Taurine 6. Advances in Experimental Medicine and Biology, vol 583. Springer, Boston, MA . https://doi.org/10.1007/978-0-387-33504-9_33
Download citation
DOI: https://doi.org/10.1007/978-0-387-33504-9_33
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-32356-5
Online ISBN: 978-0-387-33504-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)